skip to content

Broker Views

Broker Forecast - Citigroup issues a broker note on GlaxoSmithKline PLC

05 July 2017 09:10

Citigroup today downgrades its investment rating on GlaxoSmithKline PLC (LON:GSK) to neutral (from buy) and set its price target at 1700p.

Story provided by StockMarketWire.com

Related Company: GSK

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?

-

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.